Sarah E. Nash, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 47,500 shares at $4.17 ($198K) on 2013-12-02, disclosed to the SEC on 2013-12-04.
Open-market purchase of $198k MACK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.17 | 47,000 | $196K | 98.9% |
| 2 | $4.35 | 500 | $2K | 1.1% |
| Total | $4.17 avg | 47,500 | $198K | 100% |
| Filing → |
| BLKB | SELL | 2024-11-13 | $260K | — | Filing → |
| BLKB | SELL | 2024-08-09 | $491K | — | Filing → |
| BBWI | SELL | 2024-06-20 | $2.0M | — | Filing → |